fashion -WSS

fashion

author：entertainment 2025-08-11 07:58:43 - browse：56

From left, STAT's Allison DeAngelis, ALS advocate Cathy Collet, Yale's Gregg Gonsalves, Sick Cells' Ashley Valentine, and Canary Advisors' Jennifer McNary at a panel at the 2024 STAT Breakthrough Summit East. STAT

NEW YORK — Over 30 years ago, Gregg Gonsalves and other AIDS activists persuaded Congress to create the accelerated approval pathway, allowing regulators to speed access to drugs for thousands of dying patients.

These days, though, Gonsalves sounds uneasy — if not mournful — of the world he helped build.

“We’re approving drugs faster and faster — [the FDA is] one of the fastest regulatory agencies in the world — we know less and less about them, and we pay more and more for them,” said Gonsalves, now a professor at Yale, at STAT Breakthrough Summit East on Thursday. “So in that way, the system is not working. We basically put access out there as this talisman of hope, but we don’t compel the companies that give us answers about what these drugs do in our bodies.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： Close Medicare's dangerous gaps in addiction treatment coverage

focus

Wikipedia

WSS

Orangutan used medicinal plant to treat wound, first time ever seen

Bird flu outbreak in cows is latest avian flu curveball

Washington mulls new rules to avert another Change Healthcare

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Key Senate committee drafts bipartisan bill to stem drug shortages

The Readout: Lenmeldy, GLP

hotspot

fashion

hotspot

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

The Readout: Lenmeldy, GLP

In Memoriam: Notable people who died in 2023

Why the world’s most expensive drug might be worth the price

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: Novavax stock, FogPharma, Novo Nordisk

Medicare details structure of new drug price negotiation program

Element Biosciences CEO lays out genome sequencing strategy

Moonlake's readout produced a cash windfall. Risks remain

H5N1 bird flu found in pasteurized milk: what we know

focus

Close Medicare's dangerous gaps in addiction treatment coverage

Abortion pill Supreme Court ruling could impact entire drug industry

FDA's naming rule on biosimilars has undermined competition

Exact Sciences stock tumbles despite strong cancer detection sales

Patient advocates debate FDA's accelerated approval process

Medical bills so high, Medicare adding extra digits to claim forms

Wikipedia

focus

Wikipedia

entertainment